metformin has been researched along with Sezary Syndrome in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Sezary Syndrome: A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cristofoletti, C | 1 |
| Bresin, A | 1 |
| Picozza, M | 1 |
| Picchio, MC | 1 |
| Monzo, F | 1 |
| Helmer Citterich, M | 1 |
| Passarelli, F | 1 |
| Frezzolini, A | 1 |
| Scala, E | 1 |
| Monopoli, A | 1 |
| Cantonetti, M | 1 |
| Benucci, R | 1 |
| D'Atri, S | 1 |
| Caprini, E | 1 |
| Russo, G | 1 |
| Narducci, MG | 1 |
1 other study available for metformin and Sezary Syndrome
| Article | Year |
|---|---|
Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance.
Topics: Biomarkers; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Copy Number Variations; Humans; | 2019 |